
Clinical Trial
Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.
At MUSC Hollings Cancer Center, our board-certified hematologist oncologists specialize in diseases of the blood and plasma, including:
At Hollings, you will have access to potentially lifesaving and disease-altering resources and care. Our sophisticated radiation oncology therapies, immunotherapy programs, quality blood and marrow transplant (BMT) program and clinical trials led by our physician-scientists allow our providers to tailor treatment to your needs.
You know you're in good hands at MUSC Hollings Cancer Center, the state’s only National Cancer Institute-designated cancer center. Here, you have access to the latest innovations in cancer treatment, including clinical trials, advanced surgical techniques, support services and survivorship planning. You can rest easy knowing we hold national rankings for cancer care and take a leadership role in cancer research and prevention.
The Hollings differenceYour circulatory system and lymphatic system work together to bring oxygen and nutrients to organs, remove waste and fight infection.
Your blood contains red blood cells that carry oxygen into the body and carbon dioxide out of the body, white blood cells that fight infection, platelets that clot when you are cut and plasma, which accounts for just over half of the contents of your blood.
Sometimes, something goes wrong in the production of blood or lymphatic cells. Abnormal, cancerous cells begin to accumulate and crowd out normal, healthy cells. Depending on where they start, these cancerous cells may form leukemia, lymphoma or multiple myeloma. Understanding the specific type of blood cancer that you have will determine your treatment options.
Leukemia, lymphoma, multiple myeloma and other blood diseases often don’t have signs or symptoms at first. When you do have symptoms, they are often the same as symptoms for more common conditions, like the flu or an infection. Some of the symptoms common across these conditions include:
For information about symptoms specific to each type of blood or lymphatic cancer, visit the leukemia, lymphoma, and multiple myeloma pages.
“ It shows what these people at Hollings are doing. They took me – and I was really struggling when I came here in November – and in a little bit over three months, they turned me around. ”
Ted Kopacko, CAR-T cell therapy patient and lymphoma survivor
Ted's story
Hollings has a proud history of treating people with blood and lymphatic cancers. Even before the cancer center was formed, our founding oncologist, Robert Stuart, M.D., performed the first bone marrow transplant in South Carolina in 1987. Since then, our researchers and doctors have continued to collaborate to improve treatment for these cancers.
Treatment for blood cancers can include:
To refer a blood cancer patient to Hollings, please call patient referral coordinator Debra Oree (843-985-0567).
Our blood and lymphatic cancer nurse navigators, Bonnie Boyce, BSN, RN, OCN, and Katie Fitzmaurice, RN, BSN, CPN, will help you understand what to expect during treatment and answer questions you may have.
For certain patients, Hollings offers CAR-T cell therapy, which is an innovative treatment that can be very powerful. In the lab, your T-cells are primed to attack a protein found on cancer cells and then returned to your body as more efficient and effective cancer fighters.
CAR-T Cell TherapyEach day, Hollings researchers are studying how to improve treatment and give you the best outcome possible. Some recent research includes:
In addition, Hollings’ dedicated Hematologic Malignancies Transdisciplinary Cancer Team brings together expertise from different disciplines in basic and clinical research for monthly meetings to collaborate on ongoing blood and lymphatic cancer research.
As South Carolina’s only NCI-designated cancer center, Hollings offers you clinical trials and treatments that aren’t available anywhere else in the state. These opportunities provide you with access to the latest medications, therapies, and surgical techniques that can improve your outcomes. Learn more about clinical trials at Hollings and see our current blood and lymphatic cancer clinical trials, leukemia clinical trials, lymphoma clinical trials, and multiple myeloma clinical trials.
We pride ourselves on our holistic approach to cancer care. We offer you many resources to help you throughout your cancer journey, including financial counseling, physical therapy, nutrition services, and support groups.
Patient Resources86 Jonathan Lucas Street
Charleston, SC 29425
Scheduling: 843-792-9300
Hollings Cancer Center
86 Jonathan Lucas Street
Floor: Two & Three
Charleston, SC 29425
Scheduling: 843-792-9300
East Cooper Medical Pavilion
1600 Midtown Avenue
Floor: 3
Mount Pleasant, SC 29464
Scheduling: 843-792-9300
2575 Elms Center Road
Suite: 100
North Charleston, SC 29406
Scheduling: 843-792-9300
Ashley River Tower
25 Courtenay Drive
Floor: 2
Charleston, SC 29425
Scheduling: 843-792-9200
Florence Medical Center
Medical Mall A
805 Pamplico Highway
Suite: 315
Florence, SC 29505
Scheduling: 843-792-9300
1315 Roberts Street
Camden, South Carolina 29020
Leukemia, lymphoma, multiple myeloma and other blood and lymphatic cancers can occur in anyone. Most of the risk factors for these conditions aren’t things that you can change. However, Hollings always encourages healthy behaviors, like maintaining a healthy weight, eating a healthy diet filled with vegetables and fruit, exercising, and not smoking or stopping smoking. These lifestyle factors can reduce your risk of many types of cancer and can help you to be in better condition going into treatment if you should be diagnosed with cancer.
Some of the blood cancer risk factors include:
Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.
MUSC's pediatric/adult bone marrow transplant program is one of 12 across the U.S. that performed better than expected, according to a new report.
The Blood and Bone Marrow Transplant team recently celebrated 3,000 transplants – and patient Kennedy Golden exemplifies why they do what they do.